6533b81ffe1ef96bd12783b2
RESEARCH PRODUCT
Phase II trial to evaluate efficacy and tolerance of regorafenib monotherapy in patients (pts) over 70 with previously treated metastatic colorectal adenocarcinoma (mCRC) FFCD 1404 - REGOLD
M. Ben AbdelghaniG. Des GuetzEric AssenatC. Le FollOlivier RomanoJean-louis LegouxCôme LepageL. CanyM. DhoogeCatherine DelbaldoA. Darut JouveThomas AparicioDenis SmithM. DulucClaire FalandryFaiza KhemissaYves RinaldiPascal ArtruCarole MonterymardBruno Valenzasubject
Brachial Plexus Neuritismedicine.medical_specialtybusiness.industryPhases of clinical researchHematologyGastroenterology03 medical and health sciencesLarge Intestine Adenocarcinomachemistry.chemical_compound0302 clinical medicineOncologychemistry030220 oncology & carcinogenesisInternal medicineRegorafenibmedicine030211 gastroenterology & hepatologyColorectal adenocarcinomaIn patientPreviously treatedbusinessyear | journal | country | edition | language |
---|---|---|---|---|
2018-10-01 | Annals of Oncology |